Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E2020 (Aricept) in Dementia With Lewy Bodies
NCT00543855Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Nov 2007
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of donepezil in dementia with Lewy bodies (DLB) (4 arms), sponsored by Eisai Co., Ltd. Primary endpoints: Mini-mental State Examination at 12 weeks, Neuropsychiatric Inventory at 12 weeks and 2 more. Started Nov 2007; status: completed.
02
Drugs
donepezil
03
Conditions
dementia with Lewy bodies (DLB)
Beyond the preview
Go deeper on NCT00543855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00543855.